The Impact of ACE Inhibitors and Angiotensin Receptor Blockers on Aerobic Capacity and VO2 Max in Patients Undergoing Endurance Training
DOI:
https://doi.org/10.12775/QS.2026.55.70970Keywords
ACE inhibitors, Angiotensin receptor blockers, VO2 max, aerobic capacity, endurance training, hypertension, cardiorespiratory fitnessAbstract
Background. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) are foundational pharmacological therapies for hypertension and cardiovascular diseases. However, their potential interference with physiological adaptations to endurance training, particularly maximal aerobic capacity (VO2 max), remains a critical concern for clinicians and athletes.
Aim. This review aims to synthesize the current evidence regarding the impact of ACEi and ARB therapy on VO2 max, hematological parameters, and cardiac remodeling in patients and healthy individuals undergoing structured endurance training.
Material and methods. A narrative review was conducted using PubMed, Google Scholar, and the archives of the Journal of Education, Health and Sport and Quality in Sport. Search terms included "ACE inhibitors," "angiotensin receptor blockers," "VO2 max," and "endurance training." Inclusion criteria focused on peer-reviewed articles published between 2015 and 2025, emphasizing human clinical trials and systematic reviews.
Results. Evidence suggests that while chronic RAAS inhibition does not significantly attenuate relative VO2 max gains in hypertensive populations or those with metabolic syndrome, it may compromise specific physiological determinants. Notably, ACEi treatment has been associated with a reduction in total hemoglobin mass expansion and a blunting of lean mass accrual. Furthermore, sex-specific responses indicate that women may experience a more pronounced inhibition of aerobic adaptations compared to men when using standard ARB dosages.
Conclusions. ACEi and ARBs are generally compatible with aerobic exercise; however, their impact on hematological and morphological adaptations requires careful consideration, especially in high-performance or female cohorts. Exercise remains a vital synergistic co-therapy for managing hypertension alongside these medications.
References
1. Hegde, S. M., & Solomon, S. D. (2015). Influence of physical activity on hypertension and cardiac structure and function. Current Hypertension Reports, 17(10), 77. https://doi.org/10.1007/s11906-015-0588-3
2. Evans, M., Lewis, R. D., Morgan, A. R., Whyte, M. B., Hanif, W., Bain, S. C., Davies, S., Dashora, U., Yousef, Z., Patel, D. C., & Strain, W. D. (2022). A narrative review of chronic kidney disease in clinical practice: Current challenges and future perspectives. Advances in Therapy, 39(1), 33–43. https://doi.org/10.1007/s12325-021-01927-z
3. Nurhidayah, O., & Rosyid, F. N. (2026). The effect of physical activity on blood pressure in hypertensive patients: A literature review. Indonesian Journal of Global Health Research, 8(2), 627–632. https://jurnal2.globalhealthsciencegroup.com/index.php/IJGHR/article/view/749
4. Fiega, J., Lubaszka, Z., Michalska, M., Żurek, U., Szewczyk, D., & Sikorska, E. (2023). Influence of sport activity on hypertension - literature review. Journal of Education, Health and Sport, 33(1), 100–117. https://doi.org/10.12775/JEHS.2023.33.01.011
5. Koziński, T., Donderska, M., Kwiatkowski, M., Bochniak, P., Kołacz, J., Oleś, P., Bryła, M., Bryła, Z., Spaczyńska-Kwiatkowska, M., & Włoch, T. (2025). The impact of aerobic exercise on overall health, chronic disease management and COVID-19 outcomes: A literature review. Journal of Education, Health and Sport, 80, 58422. https://doi.org/10.12775/JEHS.2025.80.58422
6. Labrador-Sanchez, I., Moreno-Cabañas, A., Gonzalez-Garcia, L., Mora-Gonzalez, D., Mora-Rodriguez, R., & Morales-Palomo, F. (2026, February 5). Effects of chronic angiotensin inhibition on exercise cardiovascular adaptations [Preprint]. medRxiv. https://doi.org/10.64898/2026.02.03.26345524
7. Peresuodei, T. S., Gill, A., Orji, C., Reghefaoui, M., Saavedra Palacios, M. S., & Nath, T. S. (2024). A comparative study of the safety and efficacy between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the management of hypertension: A systematic review. Cureus, 16(2), e54311. https://doi.org/10.7759/cureus.54311
8. Brown, N. J., & Vaughan, D. E. (1998). Angiotensin-converting enzyme inhibitors. Circulation, 97(14), 1411–1420. https://doi.org/10.1161/01.CIR.97.14.1411
9. Solarz, A., Szabelski, S., Skibicka, K., Kryślak, J., Sokołowski, M., & Oskroba, K. (2025). The effect of physical activity on hypertension: Literature review. International Journal of Innovative Technologies in Social Science, 4(48), 4327. https://doi.org/10.31435/ijitss.4(48).2025.4327
10. . Kumar, R., Singh, P., Sharma, A., Patel, M., & Verma, S. (2024). The impact of aerobic exercise on athletic performance in recovered and uninfected COVID-19 athletes during post-COVID-19 period. International Journal of Sport Sciences and Health, 6(2), 112–121. https://journals.kmanpub.com/index.php/Intjssh/article/download/2176/2633/7948
11. Wu, Z., Preobrazenski, N., Renwick, J. R. M., Khansari, A., LeBouedec, M. A., Nuttall, J. M. G., Mudwi, A., Ross, B., Simpson-Stairs, N., Beaupré, L. P. R., Swinton, P. A., & Gurd, B. J. (2026). Aerobic exercise training and VO₂max: A scoping review of study populations and protocols. Journal of Functional Morphology and Kinesiology, 11(1), 70. https://doi.org/10.3390/jfmk11010070
12. Guo, M., Liu, X., Dixon, S.-M., Tse, H.-F., & Montero, D. (2025). Effects of angiotensin II receptor type 1 blockade combined with endurance training on haemoglobin mass and aerobic capacity: A randomized placebo-controlled trial. Cardiovascular Research, 121(18), 2830–2833. https://doi.org/10.1093/cvr/cvaf213
13. Sjúrðarson, T., Bejder, J., Breenfeldt Andersen, A., Bonne, T., Kyhl, K., Róin, T., Patursson, P., Gregersen, N. O., Skoradal, M. B., Schliemann, M., Lindegaard, M., Weihe, P., Mohr, M., & Nordsborg, N. B. (2022). Effect of angiotensin-converting enzyme inhibition on cardiovascular adaptation to exercise training. Physiological Reports, 10(13), e15382. https://doi.org/10.14814/phy2.15382
14. Valdivieso, P., Vaughan, D., Laczko, E., Brogioli, M., Waldron, S., Rittweger, J., & Flück, M. (2017). The metabolic response of skeletal muscle to endurance exercise is modified by the ACE-I/D gene polymorphism and training state. Frontiers in Physiology, 8, 993. https://doi.org/10.3389/fphys.2017.00993
15. Ferder, L., Inserra, F., Romano, L., Ercole, L., & Pszenny, V. (1993). Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse. American Journal of Physiology-Cell Physiology, 265(1 Pt 1), C15–C18. https://doi.org/10.1152/ajpcell.1993.265.1.C15
16. Bangalore, S., Fakheri, R., Toklu, B., Ogedegbe, G., Weintraub, H., & Messerli, F. H. (2016). Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials. Mayo Clinic Proceedings, 91(1), 51–60. https://doi.org/10.1016/j.mayocp.2015.10.019
17. Cooke, G. A., Williams, S. G., Marshall, P., Al-Timman, J. K., Shelbourne, J., Wright, D. J., & Tan, L.-B. (2002). A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients. European Heart Journal, 23(17), 1360–1368. https://doi.org/10.1053/euhj.2001.3112
18. Li, E. C., Heran, B. S., & Wright, J. M. (2014). Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database of Systematic Reviews, 2014(8), CD009096. https://doi.org/10.1002/14651858.CD009096.pub2
19. Canada’s Drug Agency. (2010). Angiotensin-converting enzyme (ACE) inhibitors: A comparative effectiveness review. https://www.cda-amc.ca/sites/default/files/pdf/htis/Angiotensin-Converting_Enzyme-AC E-inhibitors_Comparative_Effectiveness_Review.pdf
20. Sun, W., Zhang, H., Guo, J., Zhang, X., Zhang, L., Li, C., & Zhang, L. (2016). Comparison of the efficacy and safety of different ACE inhibitors in patients with chronic heart failure: A PRISMA-compliant network meta-analysis. Medicine, 95(6), e2554. https://doi.org/10.1097/MD.0000000000002554
21. Chen, R., Suchard, M. A., Krumholz, H. M., Schuemie, M. J., Shea, S., Duke, J., Tasse, A. M., Bennett, D., Huser, V., Ryan, P. B., Hripcsak, G., & others. (2021). Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: A multinational cohort study. Hypertension, 78(3), 591–603. https://doi.org/10.1161/HYPERTENSIONAHA.120.16667
22. Caulfield, L., Heslop, P., Walesby, K. E., Sumukadas, D., Sayer, A. A., & Witham, M. D. (2021). Effect of angiotensin system inhibitors on physical performance in older people: A systematic review and meta-analysis. Journal of the American Medical Directors Association, 22(6), 1215–1221.e2. https://doi.org/10.1016/j.jamda.2020.07.012
23. Blanchet, M., Sheppard, R., Racine, N., Ducharme, A., Curnier, D., Tardif, J. C., Sirois, P., Lamoureux, M. C., De Champlain, J., & White, M. (2005). Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure. American Heart Journal, 149(5), 938.e1–938.e7. https://doi.org/10.1016/j.ahj.2004.11.011
24. Lee, V. C., Rhew, D. C., Dylan, M., Badamgarav, E., Braunstein, G. D., & Weingarten, S. R. (2004). Meta-analysis: Angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction. Annals of Internal Medicine, 141(9), 693–704. https://doi.org/10.7326/0003-4819-141-9-200411020-00011
25. Xie, C., Chen, R., Zhou, S., Lin, Y., Liu, J., Su, L., Pang, M., Guo, Z., Luo, F., Chen, L., Kong, Y., & Nie, S. (2025). Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: Multidatabase target trial emulation studies. Hypertension, 82(12), 2072–2081. https://doi.org/10.1161/HYPERTENSIONAHA.125.25549
26. Ryu, T., Seo, Y. J., Lee, J., Han, J. W., Yang, H., Yang, K., Kim, K., Park, S. H., Jung, E. S., Kim, H. Y., & Bangalore, S. (2025). Class-specific effects of ARBs versus ACE inhibitors on survival and cardiovascular outcomes in MASLD. International Journal of Molecular Sciences, 26(20), Artykuł 10061. https://doi.org/10.3390/ijms262010061
27. Koman, A. M., Chamera-Cyreka, K., Pliszka, M., Janik, I., Gadżala, K., Palacz, K. A., Kułak, K. B., & Sztybór, I. (2024). The beneficial effects of aerobic exercise on human systems and organs: A literature review. Journal of Education, Health and Sport, 73, 51710. https://doi.org/10.12775/JEHS.2024.73.51710
28. . Boutagy, N. E., Marinik, E. L., McMillan, R. P., Anderson, A. S., Frisard, M. I., Davy, B. M., Rivero, J. M., Davy, K. P., & Hulver, M. W. (2015). Angiotensin II receptor blockade and skeletal muscle metabolism in overweight and obese adults with elevated blood pressure. Therapeutic Advances in Cardiovascular Disease, 9(2), 45–50. https://doi.org/10.1177/1753944714566426
29. Harper, S. A., Baptista, L. C., Roberts, L. M., Wherry, S. J., Boxer, R. S., Hildreth, K. L., Seay, R. S., Allman, P. H., Carter, C. S., Aban, I., Kohrt, W. M., & Buford, T. W. (2020). Angiotensin converting enzyme inhibitors combined with exercise for hypertensive seniors (the ACES trial): Study protocol of a randomized controlled trial. Frontiers in Medicine, 6, 327. https://doi.org/10.3389/fmed.2019.00327
30. Yang, Y., Banerjee, A., Sun, Y., Carter, C. S., & Buford, T. W. (2021). Interactive effects of enalapril administration and novel HIIT wheel-bed training in aged rats. Frontiers in Rehabilitation Sciences, 2, 764686. https://doi.org/10.3389/fresc.2021.764686
31. Fagard, R., Staessen, J., Thijs, L., & Amery, A. (1993). Influence of antihypertensive drugs on exercise capacity. Drugs, 46(Suppl 2), 32–36. https://doi.org/10.2165/00003495-199300462-00007
32. Abdulla, J., Pogue, J., Abildstrøm, S. Z., Køber, L., Christensen, E., Pfeffer, M. A., Yusuf, S., & Torp-Pedersen, C. (2006). Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction—A meta-analysis. European Journal of Heart Failure, 8(1), 90–96. https://doi.org/10.1016/j.ejheart.2005.03.006
33. Rankinen, T., Pérusse, L., Gagnon, J., Chagnon, Y. C., Leon, A. S., Skinner, J. S., Wilmore, J. H., Rao, D. C., & Bouchard, C. (2000). Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. Journal of Applied Physiology, 88(3), 1029–1035. https://doi.org/10.1152/jappl.2000.88.3.1029 training. Physiological Reports, 10(13), e15382. https://doi.org/10.14814/phy2.15382
34. Sjúrðarson, T., & Nordsborg, N. B. (2025). Angiotensin-converting enzyme and exercise adaptations: Genetic variability, pharmacological modulation and future directions. The Journal of Physiology. https://doi.org/10.1113/JP288202
35. Symons, J. D., & Stebbins, C. L. (1996). Effects of angiotensin II receptor blockade during exercise: Comparison of losartan and saralasin. Journal of Cardiovascular Pharmacology, 28(2), 223–231. https://doi.org/10.1097/00005344-199608000-00007
36. Day, S. H., Gohlke, P., Dhamrait, S. S., & Williams, A. G. (2007). No correlation between circulating ACE activity and VO₂max or mechanical efficiency in women. European Journal of Applied Physiology, 99(1), 11–18. https://doi.org/10.1007/s00421-006-0309-3
37. . Sommers, L., Akam, L., Hunter, D. J., Bhatti, J. S., & Mastana, S. (2024). Role of the ACE I/D polymorphism in selected public health-associated sporting modalities: An updated systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 21(11), 1439. https://doi.org/10.3390/ijerph21111439
38. Żuberek, M., Popińska, Z., Ślusarczyk, D., Żmuda, B., Jakubowska, W., Pisera, P., Kiełkowicz, A., & Pactwa, F. (2023). A review on the classification and current treatment of chronic kidney disease. Journal of Education, Health and Sport, 49(1), 86–106. https://doi.org/10.12775/JEHS.2023.49.01.006
39. . Elendu, C., Elendu, R. C., Enyong, J. M., Ibhiedu, J. O., Ishola, I. V., Egbunu, E. O., Meribole, E. S., Lawal, S. O., Okenwa, C. J., Okafor, G. C., Umeh, E. D., Mutalib, O. O., Opashola, K. A., Fatoye, J. O., Awotoye, T. I., Tobih-Ojeanelo, J. I., Ramon-Yusuf, H. I., Olanrewaju, A., Afuh, R. N., Adenikinju, J., Amosu, O., & Yusuf, A. (2023). Comprehensive review of current management guidelines of chronic kidney disease. Medicine, 102(23), e33984. https://doi.org/10.1097/MD.0000000000033984
40. Ogino, K., Kato, M., Noguchi, N., Kitamura, H., Osaki, S., Omodani, H., Matsumoto, T., Kinugawa, T., Miyakoda, H., Kotake, H., & Mashiba, H. (1997). Effects of enalapril on the exercise capacity and neurohumoral factors during exercise in patients with chronic heart failure. Cardiology, 88(1), 6–13. https://doi.org/10.1159/000177302
41. Begue, G., Ahmadi, A., Hayden, C. M. T., Foster, A., Rehman, U., Norman, J. E., Vargas, C., Bennett, B. J., McDonald, C., Ikizler, T. A., Hamdan, H., Smith, L., Kim, T. Y., Jue, T., Gamboa, J., & Roshanravan, B. (2025). A pilot randomized trial of home-based, video-supervised exercise on muscle metabolism and physical endurance in chronic kidney disease. medRxiv. https://doi.org/10.1101/2025.05.27.25328460
42. El Tahan, O., Youssef, G., Baghdady, Y., Abdelghany, M., & Mohsen, A. (2025). Short-term effects of exercise training program on patients with compensated chronic heart failure. Cor et Vasa, 67(5). https://actavia.e-coretvasa.cz/pdfs/cor/2025/05/10.pdf
43. . Marzetti, E., Calvani, R., DuPree, J., Lees, H. A., Giovannini, S., Seo, D. O., Buford, T. W., Sweet, K., Morgan, D., Strehler, K. Y., Diz, D., Borst, S. E., Moningka, N., Krotova, K., & Carter, C. S. (2013). Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle. Age, 35(4), 1061–1075. https://doi.org/10.1007/s11357-012-9428-4
44. . Kakutani, N., Takada, S., Nambu, H., Matsumoto, J., Furihata, T., Yokota, T., Fukushima, A., & Kinugawa, S. (2020). Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice. Skeletal Muscle, 10(1), 11. https://doi.org/10.1186/s13395-020-00230-9
45. . Cancela-Carral, J. M., Bezerra, P., López-Rodríguez, A., & Silva, B. (2025). Differential effects of the type of physical exercise on blood pressure in independent older adults. Sports Health, 17(5), 1020–1027. https://doi.org/10.1177/19417381241303706
46. Kołodziej, W., Mańdziuk, D., Żuchowski, M., Niewinna, P., Zaroda, P., Dąda P, et al. (2024). The influence of various types of physical activity on blood pressure: A literature review. Quality in Sport, 16, 52494. https://doi.org/10.12775/QS.2024.16.52494
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mateusz Kowalski, Michał Rucki, Nikodem Cieleban, Aleksandra Maria Rucka, Magdalena Modliborska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 50
Number of citations: 0
